Psilocybin and Antidepressants: Two Different Approaches

In the United States, 19.3% of adults, nearly 1 in 5, took prescription medication for their mental health in the past 12 months, according to the 2024 National Health Interview Survey.

The problem is that when we start experiencing feelings that we like to label in Western society as “negative” or uncomfortable, like grief, sadness, or pain, we believe that they don’t belong to us. We don’t accept them, and we don’t like to sit with them, so we go and reach for something else.

But how are you going to know happiness without sadness?

And antidepressants don’t just numb your sadness. They can also numb your joy. That’s why so many more people are coming forward, reaching out to psychedelics, and exploring alternatives to SSRI medication.

Nothing in this article is a reason to stop a medication you were prescribed, or to change a dose on your own. Coming off an antidepressant has its own risks and belongs in a conversation with the doctor who prescribed it.

1. Managing the Symptoms vs. Exploring What Is Underneath

Antidepressants primarily work by changing neurotransmitter signaling to help reduce symptoms of depression and anxiety. For many people, they can provide meaningful relief and stability. However, they can also come with side effects such as sexual dysfunction, sleep changes, nausea, headaches, and emotional blunting, where a person may feel less of both painful and pleasurable emotions.

Psychedelic work takes a different approach. Rather than focusing only on reducing symptoms, psilocybin may help create an opportunity to explore what is underneath them: emotions, memories, beliefs, and patterns that may be contributing to suffering. Research also suggests that psilocybin can promote neuroplasticity, the brain’s ability to form and reorganize neural connections, potentially creating a window for new ways of thinking, feeling, and responding.

Whether used at a psychedelic dose or in emerging research on lower-dose approaches, the focus is not simply on changing how you feel. It can be about changing how you relate to your inner world, and to your emotions.

2. Psychedelics Are a Tool: Learning to Work With Your Emotions

Psychedelics are not the healing itself. They are a tool that can help you access the capacity to heal.

They can create an opportunity to sit with emotions and experiences that we may normally avoid, suppress, or feel overwhelmed by. With preparation, therapeutic support, and integration, the experience can help us develop a greater capacity to tolerate discomfort, process emotions, and respond to them differently.

Combined with practices such as mindfulness, meditation, yoga, breathwork, and self-awareness, these experiences can support new patterns of thinking and emotional processing and may take advantage of periods of increased neuroplasticity.

Over time, we can begin to understand that emotions aren’t necessarily “good” or “bad.” They are information and part of being human. The goal isn’t to eliminate difficult emotions, but to develop the capacity to sit with them, understand them, and choose how to respond.

Different psychedelic medicines may support different therapeutic processes. For example, research on MDMA-assisted therapy has shown its potential in helping people remain emotionally engaged while revisiting traumatic experiences, supporting the therapeutic processing of trauma.

3. Side Effects: Understanding the Difference

Antidepressants can be helpful, but they are also medications that are taken regularly and can produce unwanted effects, particularly for some people over longer periods of treatment. These can include sexual dysfunction and loss of libido, emotional blunting or feeling numb and disconnected, sleep disturbances, nausea, headaches, weight changes, and other medication-specific effects.

Psychedelics work differently. They are generally used intermittently rather than as a daily medication, and clinical research on psilocybin has found that the physical effects reported in therapeutic settings, such as nausea, headache, dizziness, temporary anxiety, or increases in blood pressure, are generally acute and short-lived.

But “psychedelics” are not one substance, and safety depends on the medicine being used. Ibogaine, for example, carries a rare but serious risk of cardiac rhythm abnormalities, which makes thorough medical screening and appropriate monitoring essential.

This is why psychedelic-assisted work should never be reduced to simply taking a substance. Preparation, screening, the therapeutic container, the session itself, and integration are all part of the process.

When approached responsibly, the intention is not to numb, suppress, or escape the emotional experience, but to create the conditions in which a person can safely experience, process, and learn from it.

My previous article covers what integration actually involves, and why it is the part that decides whether anything changes.